Back to top

zacks-consensus-estimate: Archive

Zacks Equity Research

Will OSI (OSIS) Beat Estimates Again in Its Next Earnings Report?

OSI (OSIS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

OSISNegative Net Change

Zacks Equity Research

Can K12 (LRN) Keep the Earnings Surprise Streak Alive?

K12 (LRN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

LRNNegative Net Change

Zacks Equity Research

Will Axos Financial (AX) Beat Estimates Again in Its Next Earnings Report?

Axos Financial (AX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

AXPositive Net Change

Zacks Equity Research

ELUTIA INC (ELUT) Upgraded to Buy: Here's What You Should Know

ELUTIA INC (ELUT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ELUTNegative Net Change

Zacks Equity Research

All You Need to Know About Cactus (WHD) Rating Upgrade to Strong Buy

Cactus (WHD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

WHDPositive Net Change

Zacks Equity Research

All You Need to Know About Prenetics Global (PRE) Rating Upgrade to Buy

Prenetics Global (PRE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PREPositive Net Change

Zacks Equity Research

USCB Financial (USCB) Upgraded to Strong Buy: Here's What You Should Know

USCB Financial (USCB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

USCBNegative Net Change

Zacks Equity Research

All You Need to Know About Encompass Health (EHC) Rating Upgrade to Buy

Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

EHCPositive Net Change

Zacks Equity Research

Acuity (AYI) Upgraded to Buy: Here's Why

Acuity (AYI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AYIPositive Net Change

Zacks Equity Research

Gitlab (GTLB) Upgraded to Strong Buy: Here's What You Should Know

Gitlab (GTLB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

GTLBNegative Net Change

Zacks Equity Research

Contineum Therapeutics, Inc. (CTNM) Upgraded to Buy: What Does It Mean for the Stock?

Contineum Therapeutics, Inc. (CTNM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CTNMNegative Net Change

Zacks Equity Research

What Makes Steven Madden (SHOO) a New Strong Buy Stock

Steven Madden (SHOO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SHOOPositive Net Change

Zacks Equity Research

Baytex (BTE) Upgraded to Strong Buy: What Does It Mean for the Stock?

Baytex (BTE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BTEPositive Net Change

Zacks Equity Research

Earnings Preview: Kura Sushi (KRUS) Q1 Earnings Expected to Decline

Kura Sushi (KRUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

KRUSPositive Net Change

Zacks Equity Research

Analysts Estimate Jefferies (JEF) to Report a Decline in Earnings: What to Look Out for

Jefferies (JEF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

JEFPositive Net Change

Zacks Equity Research

Earnings Preview: Constellation Brands (STZ) Q3 Earnings Expected to Decline

Constellation Brands (STZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

STZPositive Net Change

Zacks Equity Research

Franklin Covey (FC) Expected to Beat Earnings Estimates: Should You Buy?

Franklin Covey (FC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FCNegative Net Change

Zacks Equity Research

AZZ (AZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

AZZ (AZZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AZZPositive Net Change

Zacks Equity Research

Wall Street Analysts See a 68.54% Upside in WeRide Inc. (WRD): Can the Stock Really Move This High?

The consensus price target hints at a 68.5% upside potential for WeRide Inc. (WRD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

WRDPositive Net Change

Zacks Equity Research

Wall Street Analysts See a 60.47% Upside in Ooma (OOMA): Can the Stock Really Move This High?

The mean of analysts' price targets for Ooma (OOMA) points to a 60.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

OOMANegative Net Change

Zacks Equity Research

Wall Street Analysts See a 91.49% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 91.5% in Contineum Therapeutics, Inc. (CTNM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

CTNMNegative Net Change

Zacks Equity Research

Does Daktronics (DAKT) Have the Potential to Rally 29.17% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 29.2% in Daktronics (DAKT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

DAKTNegative Net Change

Zacks Equity Research

Why This 1 Business Services Stock Could Be a Great Addition to Your Portfolio

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

VNegative Net Change

Zacks Equity Research

SBA Communications (SBAC) Upgraded to Buy: What Does It Mean for the Stock?

SBA Communications (SBAC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SBACNegative Net Change

Zacks Equity Research

Cincinnati Financial (CINF) Upgraded to Buy: What Does It Mean for the Stock?

Cincinnati Financial (CINF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CINFNegative Net Change